GSK’s Malaria Vaccine Phase 3 Study Containing Agenus’ QS-21 Published in The Lancet.The study demonstrated a statistically significant reduction against malaria in children who received RTS,S followed by a booster shot of the vaccine at 18 months.
Source:
www.businesswire.com/news/home/20150424005175/en/GSK%E2%80%99s-Malaria-Vaccine-Phase-3-Study-Agenus%E2%80%99#.VTotK6W1Gko
Source:
www.businesswire.com/news/home/20150424005175/en/GSK%E2%80%99s-Malaria-Vaccine-Phase-3-Study-Agenus%E2%80%99#.VTotK6W1Gko
No comments:
Post a Comment